Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod
Phase 1 Terminated
23 enrolled
AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors
Phase 1 Completed
27 enrolled
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Phase 1 Completed
32 enrolled
SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
39 enrolled
Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy
Phase 1 Withdrawn
Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Phase 1 Completed
18 enrolled
Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
Phase 1 Completed
45 enrolled
AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors
Phase 1 Completed
33 enrolled
Radiofrequency Therapy-Induced Endogenous Heat-Shock Proteins With or Without Radiofrequency Ablation or Cryotherapy in Treating Patients With Stage IV Melanoma
Phase 1 Completed
11 enrolled
Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma
Phase 1 Completed
18 enrolled
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Phase 1 Completed
9 enrolled
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
Phase 1 Completed
7 enrolled
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
Phase 1 Terminated
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
Phase 1 Completed
15 enrolled
Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
54 enrolled
Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast
Phase 1 Completed
17 enrolled
FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Phase 1 Completed
44 enrolled
Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors
Phase 1 Completed
38 enrolled
Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30
Phase 1 Completed
10 enrolled
Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery
Phase 1 Terminated
17 enrolled
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer
Phase 1 Completed
16 enrolled
Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
Phase 1 Completed
9 enrolled
Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
30 enrolled
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate
Phase 1 Completed
50 enrolled
Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Phase 1 Completed
8 enrolled
GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer
Phase 1 Completed
24 enrolled
Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma
Phase 1 Completed
12 enrolled
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
Phase 1 Withdrawn
Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
22 enrolled
Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma
Phase 1 Completed
11 enrolled
Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer
Phase 1 Terminated
8 enrolled
Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant
Phase 1 Completed
49 enrolled
Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
24 enrolled
Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
Phase 1 Terminated
15 enrolled